CRVS

Corvus Pharmaceu

• TipRanks·03/16 10:18

  Mizuho Securities Sticks to Its Buy Rating for Corvus Pharmaceuticals (CRVS)

• TipRanks·03/16 07:36

  Barclays Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)

• TipRanks·03/14 00:11

  Corvus Pharmaceuticals Bets Big on Soquelitinib Pipeline

• Reuters·03/13 13:35

  CORVUS PHARMACEUTICALS <CRVS.O>: OPPENHEIMER RAISES TARGET PRICE TO $33 FROM $32

• Reuters·03/13 13:31

  BUZZ-U.S. STOCKS ON THE MOVE-PayPay Corp, Ulta Beauty, InMode

• TipRanks·03/13 13:21

  Corvus Pharmaceuticals Expands Equity Sales Capacity to $200 Million

• Reuters·03/13 12:58

  BUZZ-Biotech Corvus expands stock sale agreement with Jefferies, shares down

• Reuters·03/13 12:47

  CORVUS PHARMACEUTICALS INC - AMENDED SALES AGREEMENT PROVIDES JEFFERIES ENTITLED TO COMMISSION UP TO 3.0% OF GROSS SALES PRICE PER SHARE - SEC FILING

• Reuters·03/13 12:47

  CORVUS PHARMACEUTICALS INC - ENTERS AMENDED SALES AGREEMENT TO SELL COMMON STOCK UP TO $200 MLN - SEC FILING

• TipRanks·03/13 12:16

  Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer

• TipRanks·03/13 12:08

  Corvus Pharmaceuticals files automatic mixed securities shelf

• TipRanks·03/13 12:07

  Oppenheimer Remains a Buy on Corvus Pharmaceuticals (CRVS)

• Reuters·03/13 12:03

  CORVUS PHARMACEUTICALS INC FILES FOR MIXED SHELF ; SIZE NOT DISCLOSED - SEC FILING

• TipRanks·03/13 10:25

  Corvus Pharmaceuticals: Strengthened Cash Runway and Expanding Soquelitinib Pipeline Underpin Buy Rating and Attractive Risk‑Reward Profile

• Reuters·03/13 07:25

  U.S. RESEARCH ROUNDUP-Adobe, KLA, Ulta Beauty